EUVIMEDEUVIMED entdecken
Crossref

Histone deacetylase as a potential therapeutic target for memory dysfunction during aging and neurodegenerative disorders

Padmanabh Singh, Mahendra Kumar Thakur

Methods in Enzymology · 2026

DOI: 10.1016/bs.mie.2026.05.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Enzymology, 2026. Verfasst von Padmanabh Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Biology Laboratory, Department of Zoology, Institute of Science, Centre of Advanced Study, Banaras Hindu University, Varan…. Hauptthemen laut MEDLINE: Histone Deacetylases, Neurodegenerative Diseases, Histone Deacetylase Inhibitors, Aging. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, National Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain aging is a natural biological process characterized by gradual structural, molecular, and functional changes in the brain over time. Aging is the major risk factor for neurodegenerative diseases characterized by progressive neuronal loss, cognitive decline, and impaired motor function. In recent years, growing evidence has highlighted the importance of epigenetic regulation in the development and progression of these disorders. Among these epigenetic regulators, histone deacetylases (HDACs) have emerged as critical modulators of gene expression and neuronal function. Dysregulation of HDAC activity has been increasingly implicated in the pathogenesis of several neurodegenerative diseases. Abnormal HDAC expression or activity can alter transcription of genes involved in neuronal survival and synaptic integrity, which leads to neuronal dysfunction and degeneration. Pharmacological inhibition of HDAC activity has been shown to restore histone acetylation levels, enhance the expression of neuroprotective genes, and improve synaptic plasticity in various experimental models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DeacetylasesNeurodegenerative DiseasesHistone Deacetylase InhibitorsAgingMemory DisordersHumansAnimalsNeuronal PlasticityEpigenesis, GeneticAcetylation

Stichwörter der Autor:innen

HDAC inhibitorsHistone deacetylasesNeurodegenerationSynaptic plasticity

Substanzen

Histone DeacetylasesHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Biochemistry and Molecular Biology Laboratory, Department of Zoology, Institute of Science, Centre of Advanced Study, Banaras Hindu University, Varanasi, India.
  • Biochemistry and Molecular Biology Laboratory, Department of Zoology, Institute of Science, Centre of Advanced Study, Banaras Hindu University, Varanasi, India. Electronic address: mktian2007@gmail.com.

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India
  • National Academy of Sciences

Zitieren

APA

Singh, P., & Thakur, M. K. (2026). Histone deacetylase as a potential therapeutic target for memory dysfunction during aging and neurodegenerative disorders. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2026.05.037

Vancouver

Singh P, Thakur MK. Histone deacetylase as a potential therapeutic target for memory dysfunction during aging and neurodegenerative disorders. Methods in Enzymology. 2026. doi:10.1016/bs.mie.2026.05.037

BibTeX
@article{Singh2026,
  author = {Singh, Padmanabh and Thakur, Mahendra Kumar},
  title = {Histone deacetylase as a potential therapeutic target for memory dysfunction during aging and neurodegenerative disorders},
  journal = {Methods in Enzymology},
  year = {2026},
  doi = {10.1016/bs.mie.2026.05.037}
}
Kostenlos starten →